Updates matching "Access to Healthcare"

he U.S. House of Representatives passed the Removing Barriers to Colorectal Cancer Screening Act unanimously today.

The U.S. House of Representatives is expected to pass legislation today aimed at improving access to clinical trials for communities of color and decreasing health disparities.

More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are urging the U.S. District Court for the Southern District of New York to preserve protections in the Affordable Care Act (ACA) for lesbian, gay, bisexual, transgender and queer (LGBTQ) patients receiving health care

Washington, D.C. —The Trump administration issued a interim final rule Friday that would significantly change how Medicare pays for certain prescription drugs. The “Most Favored Nation” policy would tie Medicare drug reimbursement for certain drugs to that of prices paid in select foreign countries. A statement from the American Cancer

As millions of seniors and other enrollees select their 2021 Medicare health benefits during annual open enrollment, a new report details just how confusing the program’s appeals process can be should a patient need to appeal a claim denial for health care services or prescription drugs.

Cancer patients and survivors continue to experience potentially serious health care delays during the pandemic, and tomorrow leadership across Oklahoma will shine a light on the disparities affecting Native Americans’ cancer outcomes.

Twenty patient groups representing millions of Americans with pre-existing conditions are urging the U.S. Supreme Court to prioritize patient protections, including those for people with pre-existing conditions, when it hears oral arguments Tuesday in the case of California v. Texas ( previously Texas v. United States).

Robbinsdale, MN – The American Cancer Society Cancer Action Network (ACS CAN) hosted a virtual Congressional briefing today featuring policy and advocacy experts that addressed details in ACS CAN’s newly released report , “The Costs of Cancer: 2020 Edition.” The briefing comes just one day before the U.S. Supreme